This is an old revision of this page, as edited by Beetstra (talk | contribs) at 12:31, 24 November 2011 (Saving copy of the {{drugbox}} taken from revid 453889165 of page Metolazone for the Chem/Drugbox validation project (updated: 'DrugBank').). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 12:31, 24 November 2011 by Beetstra (talk | contribs) (Saving copy of the {{drugbox}} taken from revid 453889165 of page Metolazone for the Chem/Drugbox validation project (updated: 'DrugBank').)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)This page contains a copy of the infobox ({{drugbox}}) taken from revid 453889165 of page Metolazone with values updated to verified values. |
Clinical data | |
---|---|
Trade names | Zaroxolyn |
AHFS/Drugs.com | Monograph |
MedlinePlus | a682345 |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | ~65% |
Metabolism | kidney (minimal) |
Elimination half-life | 14 hours |
Excretion | primarily urine |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
Chemical and physical data | |
Formula | C16H16ClN3O3S |
Molar mass | 365.835 g/mol g·mol |
3D model (JSmol) | |
Melting point | 260 °C (500 °F) |
SMILES
| |
InChI
| |
(verify) |